# FDA UNTITLED_LETTER - QuVa Pharma, Inc. - September 24, 2024

Source: https://www.globalkeysolutions.net/records/untitled_letter/quva-pharma-inc/9807dbff-8897-48ee-bc96-bc877d478daf

> FDA UNTITLED_LETTER for QuVa Pharma, Inc. on September 24, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: QuVa Pharma, Inc.
- Inspection Date: 2024-09-24
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2024-10-28](https://www.globalkeysolutions.net/records/483/quva-pharma-inc/86384d71-640f-40d7-82b8-4214030ed2f4)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/frances-g-bormel/75a42bda-8a74-4dd2-a081-c7f1bf9cf417)

Company: https://www.globalkeysolutions.net/companies/quva-pharma-inc/1c3d31f9-2be4-48a3-84d3-e65f3344acd9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c